345 related articles for article (PubMed ID: 9766561)
1. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico.
Torres J; Pérez-Pérez GI; Leal-Herrera Y; Muñoz O
Int J Cancer; 1998 Oct; 78(3):298-300. PubMed ID: 9766561
[TBL] [Abstract][Full Text] [Related]
2. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
[TBL] [Abstract][Full Text] [Related]
4. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
6. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.
Blaser MJ; Perez-Perez GI; Kleanthous H; Cover TL; Peek RM; Chyou PH; Stemmermann GN; Nomura A
Cancer Res; 1995 May; 55(10):2111-5. PubMed ID: 7743510
[TBL] [Abstract][Full Text] [Related]
7. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
8. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
9. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
[TBL] [Abstract][Full Text] [Related]
10. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
11. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Helicobacter pylori CagA status and colorectal cancer.
Shmuely H; Passaro D; Figer A; Niv Y; Pitlik S; Samra Z; Koren R; Yahav J
Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957
[TBL] [Abstract][Full Text] [Related]
14. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
[TBL] [Abstract][Full Text] [Related]
15. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
18. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt.
Said Essa A; Alaa Eldeen Nouh M; Mohammed Ghaniam N; Graham DY; Said Sabry H
Scand J Infect Dis; 2008; 40(9):730-3. PubMed ID: 19086246
[TBL] [Abstract][Full Text] [Related]
20. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
